Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

Antibodies against polyethylene glycol (PEG) in healthy subjects raise concerns about the efficacy of pegylated drugs. We evaluated the prevalence of antibodies against PEG among patients with acute lymphoblastic leukemia (ALL) prior to and/or immediately after their first dose of pegylated E.coli a...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Alaeddin, Würthwein, Gudrun, Golitsch, Jana, Hempel, Georg, Fobker, Manfred, Gerss, Joachim, Möricke, Anja, Zimmermann, Martin, Smisek, Petr, Zucchetti, Massimo, Nath, Christa, Attarbaschi, Andishe, von Stackelberg, Arend, Gökbuget, Nicola, Rizzari, Carmelo, Conter, Valentino, Schrappe, Martin, Boos, Joachim, Lanvers-Kaminsky, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719085/
https://www.ncbi.nlm.nih.gov/pubmed/33299233
http://dx.doi.org/10.3324/haematol.2020.258525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719085/
https://www.ncbi.nlm.nih.gov/pubmed/33299233
http://dx.doi.org/10.3324/haematol.2020.258525

Ejemplares similares